Evidence map›Paper›PMID 38642213›Full record

ArticleAIDS and behavior2024

Characteristics of Received HIV Prevention Advocacy from Persons Living with HIV in Uganda, and Associations with HIV Testing and Condom Use Among Social Network Members.

Glenn J Wagner, Laura M Bogart, Joseph K B Matovu, Stephen Okoboi, Violet Gwokyalya, David J Klein, Susan Ninsiima, Harold D Green

Open access · hybridAbstract read
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Glenn J WagnerRAND Corporation, 1776 Main Street, Santa Monica, CA, 90407, USA. gwagner@rand.org.ORCID http://orcid.org/0000-0001-9081-3299
Laura M BogartRAND Corporation, 1776 Main Street, Santa Monica, CA, 90407, USA.
Joseph K B MatovuMakerere University School of Public Health, Kampala, Uganda.
Stephen OkoboiInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Violet GwokyalyaMakerere University School of Public Health, Kampala, Uganda.
David J KleinRAND Corporation, 1776 Main Street, Santa Monica, CA, 90407, USA.
Susan NinsiimaInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Harold D GreenUniversity of Indiana Bloomington School of Public Health, Bloomington, IN, USA.
RAND Corporation · USInfectious Diseases Institute · UGMakerere University · UGIndiana University Bloomington · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Controlled Trial of Game Changers: A Group Intervention to Train HIV Clients to be Change Agents for HIV Prevention in UgandaR01MH126691 · NIMH · RAND CORPORATION · PI BOGART, LAURA M, WAGNER, GLENN JOHN · 2021 to 2025
$4.0M
NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH126691
6 · The paper itself

Abstract

Receiving peer advocacy has been shown to result in increased HIV protective behaviors, but little research has gone beyond assessment of the mere presence of advocacy to examine aspects of advocacy driving these effects. With baseline data from a controlled trial of an advocacy training intervention, we studied characteristics of HIV prevention advocacy received among 599 social network members of persons living with HIV in Uganda and the association of these characteristics with the social network members' recent HIV testing (past six months) and consistent condom use, as well as perceived influence of advocacy on these behaviors. Participants reported on receipt of advocacy specific to HIV testing and condom use, as well as on measures of advocacy content, tone of delivery, support for autonomous regulation, and perceived influence on behavior. Receiving HIV testing advocacy and condom use advocacy were associated with recent HIV testing [65.2% vs. 51.4%; OR (95% CI) = 1.77 (1.11-2.84)], and consistent condom use with main sex partner [19.3% vs. 10.0%; OR (95% CI) = 2.16 (1.12-4.13)], respectively, compared to not receiving advocacy. Among those who received condom advocacy, perceived influence of the advocacy was positively correlated with consistent condom use, regardless of type of sex partner; support of autonomous regulation was a correlate of consistent condom use with casual sex partners, while judgmental advocacy was a correlate of consistent condom use with serodiscordant main partners. Among those who received testing advocacy, HIV testing in the past 6 months was positively correlated with receipt of direct support for getting tested. In multiple regression analysis, perceived influence of both HIV testing and condom use advocacy were positively correlated with advocacy that included access information and support of autonomous regulation; confrontational advocacy and judgmental advocacy were independent positive correlates of perceived influence of testing and condom use advocacy, respectively. These findings support associations that suggest potential benefits of peer advocacy from PLWH on HIV testing and condom use among their social network members, and indicate that advocacy content, tone of delivery, and support of autonomous regulation advocacy may play an important role in the success of advocacy.

Indexed as

CondomsHIV InfectionsHIV TestingPeer GroupSexual PartnersSocial SupportAdultFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient AdvocacySafe SexSexual BehaviorUgandaAdvocacyCondom useHIVHIV testingPeerPreventionSocial networkUganda

Identifiers

PMID38642213
PMCPMC11199098
OpenAlexW4394977982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.